SciCombinator

Discover the most talked about and latest scientific content & concepts.

J Leventhal, Y Huang, H Xu, I Goode and ST Ildstad
Abstract
Graft-versus-host disease is one of the major transplant-related complications in allogeneic hematopoietic stem cell transplantation. Continued efforts have been made to prevent the occurrence of severe graft-versus-host disease by eliminating or suppressing donor-derived effector T cells. Conventional immunosuppression does not adequately prevent graft-versus-host disease, especially in mismatched transplants. Unfortunately, elimination of donor-derived T cells impairs stem cell engraftment, and delays immunologic reconstitution, rendering the recipient susceptible to post-transplant infections and disease relapse, with potentially lethal consequences. In this review, we discuss the role of dynamic immune regulation in controlling graft-versus-host disease, and how cell-based therapies are being developed using regulatory T cells and other tolerogenic cells for the prevention and treatment of graft-versus-host disease. In addition, advances in the design of cytoreductive conditioning regimens to selectively target graft-versus-host disease-inducing donor-derived T cells that have improved the safety of allogeneic stem cell transplantation are reviewed. Finally, we discuss advances in our understanding of the tolerogenic facilitating cell population, a phenotypically and functionally distinct population of bone marrow-derived cells which promote hematopoietic stem cell engraftment while reducing the risk of graft-versus-host disease.
Tweets*
0
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
7
Concepts
Hematopoietic stem cell, Immunology, T helper cell, T cells, Organ transplant, Hematopoietic stem cell transplantation, Graft-versus-host disease, Immune system
MeSH headings
Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Humans, Immunosuppression, Immunotherapy, T-Lymphocytes, Transplantation, Homologous
comments powered by Disqus

* Data courtesy of Altmetric.com